Current situation of COVID19 is playing a huge impact on community and the health professionals in Bangladesh like any other affected country. But as a developing country with dense population it is almost impossible to identify and point out the COVID19 cases in mass population living in a non understanding situation. Curretly the testing facility for COVID19 is not available except only one centere in the capital of of Bangladesh. Also this is the time of viral flue presenting with similar symptoms like COVID19 infection. A broad spectrum antibiotic is given to treat and prevent secondary infection during this time in most of the patients. Besides as tropical country malaria is a common disease; often the treatment of malaria is offered based on symptoms only. Chloroquine has been described as a potential anti 2019-nCoV drug along with other antiviral agents. Currently Faviparavir is not available in Bangladesh. So my question is can we prescribe a early treatment in combination with Chloroquine and Azithromycin with or without Glucocorticoids (Depending on cases only) in all the suspected COVID19 cases as a routine (unless there is any existing contraindication to these drugs)? What could be the outcome? What difficulties we might face? What might be the potential risk and befinit situation regarding this regiment?

More Abu Taiub Mohammed Mohiuddin Chowdhury's questions See All
Similar questions and discussions